Body
---------- Forwarded message ----------
From: Derek from Peptide Price <derekpruski@substack.com>
Date: Mar 21, 2026 at 8:24 AM -0400
To: tjphuhs@gmail.com
Subject: MOTS-c & Morning Workout Timing — A Beginner-Friendly Breakdown
> Not medical advice, not personal advice.
> ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
> Forwarded this email? Subscribe here for more
> MOTS-c & Morning Workout Timing — A Beginner-Friendly Breakdown
> Derek
> Mar 21
>
> READ IN APP
>
> Not medical advice, not personal advice. For educational purposes only. All use cases discussed are strictly research use only.
> If a researcher is using MOTS-c and also hitting the gym in the morning, timing matters. Here’s why — broken down in plain language.
> First, What Is MOTS-c?
> MOTS-c is a small peptide encoded in mitochondrial DNA, which makes it unique among peptides. Most peptides are encoded in the cell’s nucleus. Mitochondria are the energy-producing organelles inside your cells — often called the “powerhouse of the cell.” MOTS-c is essentially a signal that mitochondria send out to communicate with the rest of the body about energy status.
> In research, it has shown strong effects on metabolism, insulin sensitivity, fat utilization, and cellular energy regulation.
> Two Pathways You Need to Understand
> To understand why timing matters, a researcher needs to understand two opposing biological pathways. Think of them like two switches in the body that generally can’t both be fully on at the same time.
> AMPK — The Low Fuel Switch
> AMPK stands for adenosine monophosphate-activated protein kinase. Just think of it as the body’s low-energy alarm system. When cellular energy is running low — during fasting, cardio, or caloric restriction — AMPK activates. Once on, it tells the body to:
>
> • > Burn fat for fuel
> • > Improve how cells use glucose
> • > Build new mitochondria
> • > Conserve energy by slowing down expensive biological processes — including building new muscle tissue
>
> MOTS-c is a potent AMPK activator. That’s largely where its metabolic benefits originate.
> mTOR — The Build and Grow Switch
> mTOR stands for mechanistic target of rapamycin. Think of this as the body’s anabolic — or growth — signal. When mTOR is activated, the body ramps up muscle protein synthesis, drives hypertrophy (muscle growth), and invests resources into repair and building.
> Resistance training is one of the most powerful ways to stimulate mTOR. Eating adequate protein and carbohydrates after training also helps keep it elevated.
> Why They Conflict
> Here’s the key point: AMPK and mTOR are opposing signals. When AMPK is highly active, it puts the brakes on mTOR. Biologically this makes sense — the body doesn’t want to be building expensive new muscle tissue when it thinks it’s in an energy-deficient state. These two pathways actively suppress each other, which is why administering a potent AMPK activator right before resistance training creates a potential conflict worth thinking about.
> The Important Nuance
> Before getting into scenarios, this needs to be stated clearly because it gets misunderstood constantly.
> Activating AMPK does not completely shut off mTOR. It does not eliminate muscle growth.
> The relationship between these two pathways is nuanced — it depends on how strongly each is activated, the researcher’s nutrition status, training intensity, recovery, and a range of other factors. A research subject is not going to lose all their gains because MOTS-c was administered before a workout. The effect is more of a partial dampening under certain conditions, not a complete block.
> There’s also a compelling wrinkle specific to MOTS-c: research has shown it can suppress myostatin. Myostatin is a protein the body produces that actively limits how much muscle can grow — it functions as a biological brake on muscle development. Lower myostatin means that brake is loosened, which can support greater skeletal muscle growth potential.
> Whether this effect is enough to fully offset any mTOR dampening from AMPK activation is still an open research question — but it makes the picture considerably more complex than simply writing off MOTS-c as counterproductive to muscle growth.
> Scenario 1 — The Optimal Approach (If Schedule Allows)
> This is the approach that theoretically extracts the most from both MOTS-c and resistance training by keeping the two signals separated.
> Step 1 — Administer MOTS-c fasted, first thing in the morning.
> Step 2 — Follow with low-to-moderate intensity movement. A walk, steady state cardio, a light bike ride. Not resistance training. In a fasted state with low-intensity activity, AMPK is heavily biased and substrate availability is low — the body is primed to respond to MOTS-c’s metabolic signals. This is the environment where its effects on mitochondrial function, fat oxidation, glucose metabolism, and metabolic flexibility are operating at full capacity with no interference.
> Step 3 — Remain in a fasted or semi-fasted state for roughly 2–4 hours. This gives the acute AMPK signaling window time to normalize.
> Step 4 — Break the fast with a solid meal. Protein, carbohydrates, adequate calories. This refuels glycogen stores, raises circulating amino acid availability, and shifts the hormonal environment toward anabolism.
> Step 5 — Train. With MOTS-c out of the acute signaling window and the body adequately refueled, resistance training can potently stimulate mTOR without meaningful AMPK interference. The anabolic response to training is uncompromised.
> The end result is two clean, well-supported signaling environments — one optimized for metabolic and mitochondrial adaptation in the morning, one optimized for muscle growth later in the day. Both get their moment.
> Scenario 2 — Morning Administration Before Resistance Training
> Not every researcher has the schedule flexibility for Scenario 1, and that’s completely fine.
> For a researcher who can only train in the morning: administer MOTS-c, train, and don’t overthink it.
> The mechanistic concern around AMPK and mTOR is real, but it is not catastrophic in a practical context. The research subject is still going to produce a meaningful training stimulus, still going to drive muscle protein synthesis, and still going to see adaptation over time. The myostatin suppression effect from MOTS-c also adds a layer that may partially compensate for any attenuation of mTOR signaling.
> Compared to Scenario 1, outcomes on the muscle growth side may be marginally less optimal — but results are still being produced on both fronts. This is not a failure mode. It is a practical, workable approach for researchers whose schedules demand it.
> The Simple Version
> Maximum benefit: Administer MOTS-c fasted in the morning, do light cardio, eat a solid meal a few hours later, then train.
> Constrained schedule: Administer MOTS-c and train in the morning anyway. Still worth it.
> For research use only, not for human consumption. This is not medical advice or personal advice — strictly educational.
> I want to give a huge shoutout to Coach Cam because he provided a lot of different perspectives on this through his research as well.
> Questions or thoughts? Drop them in the comments.
> Upgrade to paid
> You're currently a free subscriber to Peptide Price. For the full experience, upgrade your subscription.
> Upgrade to paid
>
> Share
>
>
> Like
> Comment
> Restack
>
> © 2026 Derek Pruski
> 548 Market Street PMB 72296, San Francisco, CA 94104
> Unsubscribe